ArticleBMC biology2026
scDEBGCL: a deep embedding approach based on bipartite graph contrastive learning for single-cell RNA-seq data.
Article in BMC biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundSingle-cell RNA sequencing (scRNA-seq) allows for the measurement of gene expression at the transcriptomic level with single-cell precision, thereby deepening our comprehension of cellular heterogeneity. However, the high dimensionality and sparsity of scRNA-seq data impede downstream analyses (such as cell clustering and trajectory inference), and learning effective embedded representations of the data has become a key aspect in scRNA-seq data analysis.
resultWe present scDEBGCL, a novel deep embedding algorithm based on bipartite graph contrastive learning. scDEBGCL leverages Singular Value Decomposition (SVD) for bipartite graph enhancement and integrates graph contrastive learning, graph reconstruction, and data reconstruction to jointly learn low-dimensional embedded representations of cells, which are used for downstream tasks such as cell clustering, trajectory inference, and marker gene identification. Specifically, scDEBGCL first converts the gene expression matrix into a cell-gene bipartite graph and applies SVD to this bipartite graph for graph enhancement. This strategy effectively preserves the global cell-gene interactions and facilitate the learning of global synergistic signals within the data. To further capture the discriminative cellular representations, scDEBGCL performs contrastive learning between the enhanced graph and the original bipartite graph. Then, scDEBGCL integrates the contrastive learning loss, bipartite graph reconstruction loss, and ZINB distribution-based reconstruction loss to jointly optimize and learn the low-dimensional representations of cells for downstream analyses such as cell clustering, cell trajectory inference, and marker gene identification.
conclusionsExperiments results demonstrate that scDEBGCL is a useful GCL framework for deep embedding in scRNA-seq data, providing a reliable foundation for various downstream analyses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.